- Status:
- Red
- Decision Date:
- December 2018
Comments
RED: NICE TA545: gemtuzumab with daunorubicin and cytarabine for untreated acute myeloid leukaemia.
Red Drug Classifications
- 8. NHS England commissioned – to be used in line with NHSE commissioning intentions
search again